Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
|Articles|February 18, 2008
Top 200 Brand Drugs By Units in 2007
A listing of the Top 200 Brand Drugs By Units in 2007
Advertisement
Here is a listing, provided by Verispan, of the Top 200 Brand Drugs by Unitsin 2007. The top five drugs include:
- Lipitor
- Singulair
- Lexapro
- Nexium
- Synthroid
Click
Advertisement
Related to this article
In an exploration of 2 distinct timeframes in the 21st century, researchers examine the use and concurrent use of medication types among elderly US adults.
The investigational anti–IL-33 antibody lowered exacerbation rates across all blood eosinophil levels, a benefit current COPD biologics do not offer.
This episode offers a detailed look into the FDA’s recent PCAC meeting and what the future of peptide compounding could lead to for pharmacy professionals.
A study finds children starting continuous glucose monitoring within a month of diagnosis sustained lower hemoglobin A1C than those who started later.
With obesity, muscle loss, and sleep disorders so prominent in postmenopause, providers are now looking into further expansion of GLP-1 use.
Menopause status and symptoms are inconsistently captured in electronic health records, leaving a gap in care for patients.
As midterm elections approach, the pharmacy industry is backing one of its most meaningful bills yet while the current congressional session wanes.
Advertisement
Advertisement
Trending on Drug Topics
1
Tozorakimab Reduces COPD Exacerbations in Phase 3 Trials
2
Muscle Preservation Is Key in GLP-1 Therapy for Postmenopausal Women
3
Injectable HIV Treatment Beats Daily Pills in Adolescent Trial
4
FDA Approves Onswik Weekly Insulin for Adults With T2D
5